$18.01
-1.83-9.22%
Last update: Nov 4, 4:10 PM
Cue Biopharma Inc
CUENASDAQ
The average analyst price target for Cue Biopharma is $126.63, 584.5% above the current price. Of 8 analysts, 8 rate it Buy. Targets range from $60 to $300. The latest change came on Sep 18, 2026, when B. Riley Securities initiated coverage of Cue Biopharma with a Buy rating and a $83 price target.
Price Target Range — 7 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months
